Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.9287
+0.0756 (8.86%)
At close: Oct 8, 2025, 4:00 PM EDT
0.9300
+0.0013 (0.14%)
After-hours: Oct 8, 2025, 7:19 PM EDT

Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of $77.32 million. The enterprise value is -$38.58 million.

Market Cap77.32M
Enterprise Value -38.58M

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025, after market close.

Earnings Date Nov 5, 2025
Ex-Dividend Date n/a

Share Statistics

Adicet Bio has 83.25 million shares outstanding. The number of shares has increased by 42.22% in one year.

Current Share Class 83.25M
Shares Outstanding 83.25M
Shares Change (YoY) +42.22%
Shares Change (QoQ) +0.02%
Owned by Insiders (%) 1.66%
Owned by Institutions (%) 37.76%
Float 61.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.53
P/TBV Ratio 0.53
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.48, with a Debt / Equity ratio of 0.12.

Current Ratio 7.48
Quick Ratio 7.32
Debt / Equity 0.12
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -63,086.50

Financial Efficiency

Return on equity (ROE) is -64.39% and return on invested capital (ROIC) is -39.14%.

Return on Equity (ROE) -64.39%
Return on Assets (ROA) -36.52%
Return on Invested Capital (ROIC) -39.14%
Return on Capital Employed (ROCE) -86.48%
Revenue Per Employee n/a
Profits Per Employee -$780,500
Employee Count152
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.13% in the last 52 weeks. The beta is 1.63, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y) 1.63
52-Week Price Change -34.13%
50-Day Moving Average 0.76
200-Day Moving Average 0.77
Relative Strength Index (RSI) 59.72
Average Volume (20 Days) 1,881,219

Short Selling Information

The latest short interest is 4.78 million, so 5.74% of the outstanding shares have been sold short.

Short Interest 4.78M
Short Previous Month 4.58M
Short % of Shares Out 5.74%
Short % of Float 7.72%
Short Ratio (days to cover) 9.12

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -126.17M
Pretax Income -118.64M
Net Income -118.64M
EBITDA -119.62M
EBIT -126.17M
Earnings Per Share (EPS) -$1.30
Full Income Statement

Balance Sheet

The company has $124.96 million in cash and $15.36 million in debt, giving a net cash position of $109.61 million or $1.32 per share.

Cash & Cash Equivalents 124.96M
Total Debt 15.36M
Net Cash 109.61M
Net Cash Per Share $1.32
Equity (Book Value) 133.37M
Book Value Per Share 1.60
Working Capital 110.66M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$98.14 million and capital expenditures -$2.12 million, giving a free cash flow of -$100.25 million.

Operating Cash Flow -98.14M
Capital Expenditures -2.12M
Free Cash Flow -100.25M
FCF Per Share -$1.20
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -42.22%
Shareholder Yield n/a
Earnings Yield -167.04%
FCF Yield -141.15%
Dividend Details

Analyst Forecast

The average price target for Adicet Bio is $6.00, which is 546.06% higher than the current price. The consensus rating is "Buy".

Price Target $6.00
Price Target Difference 546.06%
Analyst Consensus Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -58.19%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1